Onconix Inc.

Onconix is developing a blood test designed to accurately detect and stage cervical cancer, monitor its treatment, and provide an early warning of recurrence or metastases. The Cervical Specific Antigen test uses insulin-like growth factor II (IGF-II) as a biomarker of cervical cancer.